Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Zafgen Inc. (ZFGN)

0.7419   0.012 (1.62%) 11-19 13:28
Open: 0.7302 Pre. Close: 0.7301
High: 0.7668 Low: 0.7302
Volume: 147,294 Market Cap: 28M
Zafgen Inc is a biopharmaceutical company engaged in improving the health and well-being of patients affected by obesity and complex metabolic disorders. Its product candidate include Beloranib.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.761 - 0.765 0.765 - 0.768
Low: 0.721 - 0.725 0.725 - 0.729
Close: 0.723 - 0.73 0.73 - 0.737

Technical analysis

as of: 2019-11-19 1:02:37 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 0.93     One year: 1.08
Support: Support1: 0.74    Support2: 0.71
Resistance: Resistance1: 0.80    Resistance2: 0.93
Pivot: 0.75
Moving Average: MA(5): 0.75     MA(20): 0.75
MA(100): 0.85     MA(250): 2.51
MACD: MACD(12,26):     Signal(9):
Stochastic oscillator: %K(14,3): 47.40     %D(3): 45.88
RSI: RSI(14): 53.86
52-week: High: 9.42  Low: 0.63  Change(%): -91.8
Average Vol(K): 3-Month: 48980  10-Days: 26438

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
ZFGN has closed below upper band by 23.2%. Bollinger Bands are 72.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to ZFGN's normal range. The bands have been in this narrow range for 48 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Zafgen (NASDAQ:ZFGN) Releases Quarterly Earnings Results, Beats Expectations By $0.03 EPS
Zafgen (NASDAQ:ZFGN) announced its earnings results on Wednesday. The biopharmaceutical company reported ($0.24) EPS for the quarter, beating the consensus estimate of ($0.27) by $0.03, Fidelity Earnings reports. NASDAQ ZFGN traded up $0.02 during mid-day trading on Thursday, reaching $0.76. 457,450 shares of the company’s stock traded hands, compared to its average volume of 359,394. […]

The Daily Biotech Pulse: European Nod For Roche, Takeda Recall, Neon Exults On Journal Publication
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Sept. 5) Bioanalytical Systems, Inc. (NASDAQ: BASI ) NextCure Inc (NASDAQ: NXTC ) Pfenex Inc (NYSE: PFNX ) Protagonist Therapeutics Inc (NASDAQ: PTGX ) ResMed Inc. (NYSE: RMD ) West Pharmaceutical Services Inc. (NYSE: WST ) Down In The Dumps (Biotech stocks hitting 52-week lows on Sept. 5) Adamis Pharmaceuticals Corp (NASDAQ: ADMP ) BioNano Genomics Inc (NASDAQ: BNGO ) Endologix, Inc. (NASDAQ: ELGX ) Mallinckrodt PLC (NYSE: MNK ) ( retreated amid reports of restructuring ahead of Cleveland opioid litigation) Merit Medical Systems, Inc. (NASDAQ: MMSI ) VBI Vaccines Inc (NASDAQ: VBIV ) Zafgen Inc (NASDAQ: ZFGN ) ( announced decision to explore strategic options) See Also: Biotech Stock On The Radar: Ardelyx Gears Up For FDA Decision Day Stocks In Focus Neon's Process To Predict Neoantigens To Control Tumor Growth Published In Scientific Journal Neon Therapeutics Inc (NASDAQ: NTGN ) announced publication in the scientific journal "Immunity," a breakthrough process for predicting which neoantigens will be presented by MHC Class II molecules in the tumor microenvironment.

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 37.37
Shares Float (M) 23.62
% Held by Insiders 1.14
% Held by Institutions 88.90
Shares Short (K) 701
Shares Short P. Month (K)

Stock Financials

EPS -1.414
Book Value (p.s.) 1.600
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -27.3
Return on Equity (ttm) -64.4
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -1.306
Qtrly Earnings Growth
Operating Cash Flow (M) -42.81
Levered Free Cash Flow (M) -19.14

Stock Valuations

P/E -0.54
P/E Growth Ratio 0.05
P/BV 0.48
P/CF -0.67

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.